Literature DB >> 26245993

Survivin splice variants and their diagnostic significance.

Nand K Sah1, Chandrabhan Seniya2.   

Abstract

Survivin plays a crucial role in cell division particularly during the development of the fetus, in the onset and progression of most tumors and is found expressed in a few terminally differentiated cells. Altogether, there are ten splice variants of survivin, some of which are not yet satisfactorily characterized. Several isoforms may undergo homo/heterodimerization, particularly with the wild-type survivin to elicit a variety of biological functions. The detection of survivin and its splice variants not only suggests the onset, maintenance, and progression of cancer, but also the stage of certain cancers. Recent studies demonstrate that the presence of survivin in urine and blood samples of patients may suggest urogenital and bladder cancer hematologic malignancies, respectively. The expression of the survivin-3α splice variant is indicative of the onset and progression of breast cancer. Several companies have developed cancer diagnostic kits using survivin for detection of cancer. Some are also engaged in fine-tuning the type and stage-specific diagnosis of cancer based on survivin, its splice variants with and without other markers, such as hyaluronidase. Briefly, survivin and its splice variants hold a great biological significance, particularly in the diagnosis of cancer.

Entities:  

Keywords:  Cancer; Diagnosis; Splice variants; Survivin; p53

Mesh:

Substances:

Year:  2015        PMID: 26245993     DOI: 10.1007/s13277-015-3865-5

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  70 in total

Review 1.  Survivin study: an update of "what is the next wave"?

Authors:  Fengzhi Li; Xiang Ling
Journal:  J Cell Physiol       Date:  2006-09       Impact factor: 6.384

Review 2.  Transcriptional regulation of the survivin gene.

Authors:  Romain Boidot; Frédérique Végran; Sarab Lizard-Nacol
Journal:  Mol Biol Rep       Date:  2013-11-07       Impact factor: 2.316

3.  Do the survivin (BIRC5) splice variants modulate or add to the prognostic value of total survivin in breast cancer?

Authors:  Paul N Span; Vivianne C G Tjan-Heijnen; Joop J T M Heuvel; Jacques B de Kok; John A Foekens; Fred C G J Sweep
Journal:  Clin Chem       Date:  2006-07-27       Impact factor: 8.327

Review 4.  Spliceosome structure and function.

Authors:  Cindy L Will; Reinhard Lührmann
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-07-01       Impact factor: 10.005

Review 5.  Survivin beyond physiology: orchestration of multistep carcinogenesis and therapeutic potentials.

Authors:  Kalliopi Ch Athanasoula; Helen Gogas; Katerina Polonifi; Aristeidis G Vaiopoulos; Aristidis Polyzos; Marina Mantzourani
Journal:  Cancer Lett       Date:  2014-02-19       Impact factor: 8.679

6.  Apoptosis gene signature of Survivin and its splice variant expression in breast carcinoma.

Authors:  Frédérique Végran; Romain Boidot; Franck Bonnetain; Muriel Cadouot; Sandy Chevrier; Sarab Lizard-Nacol
Journal:  Endocr Relat Cancer       Date:  2011-12-01       Impact factor: 5.678

7.  Survivin isoform Delta Ex3 regulates tumor spheroid formation.

Authors:  Magali Espinosa; Gisela Ceballos-Cancino; Richard Callaghan; Vilma Maldonado; Nelly Patiño; Víctor Ruíz; Jorge Meléndez-Zajgla
Journal:  Cancer Lett       Date:  2011-12-08       Impact factor: 8.679

8.  Survivin-3B potentiates immune escape in cancer but also inhibits the toxicity of cancer chemotherapy.

Authors:  Frédérique Végran; Romain Mary; Anne Gibeaud; Céline Mirjolet; Bertrand Collin; Alexandra Oudot; Céline Charon-Barra; Laurent Arnould; Sarab Lizard-Nacol; Romain Boidot
Journal:  Cancer Res       Date:  2013-07-15       Impact factor: 12.701

9.  Methylation profiles of thirty four promoter-CpG islands and concordant methylation behaviours of sixteen genes that may contribute to carcinogenesis of astrocytoma.

Authors:  Jian Yu; Hongyu Zhang; Jun Gu; Song Lin; Junhua Li; Wei Lu; Yifei Wang; Jingde Zhu
Journal:  BMC Cancer       Date:  2004-09-14       Impact factor: 4.430

10.  Characterisation of the anti-apoptotic function of survivin-DeltaEx3 during TNFalpha-mediated cell death.

Authors:  M-H Malcles; H-W Wang; A Koumi; Y-H Tsai; M Yu; A Godfrey; C Boshoff
Journal:  Br J Cancer       Date:  2007-05-15       Impact factor: 7.640

View more
  13 in total

1.  Overexpression of nicotinamide N-methyltransferase in HSC-2 OSCC cell line: effect on apoptosis and cell proliferation.

Authors:  Riccardo Seta; Marco Mascitti; Roberto Campagna; Davide Sartini; Stefania Fumarola; Andrea Santarelli; Michele Giuliani; Monia Cecati; Lorenzo Lo Muzio; Monica Emanuelli
Journal:  Clin Oral Investig       Date:  2018-06-07       Impact factor: 3.573

Review 2.  Survivin at a glance.

Authors:  Sally P Wheatley; Dario C Altieri
Journal:  J Cell Sci       Date:  2019-04-04       Impact factor: 5.285

3.  Survivin DEx3 as a biomarker of thyroid cancers: A study at the mRNA and protein level.

Authors:  Joanna Waligórska-Stachura; Nadia Sawicka-Gutaj; Maciej Zabel; Mirosław Andrusiewicz; Paweł Gut; Agata Czarnywojtek; Marek Ruchała
Journal:  Oncol Lett       Date:  2017-02-10       Impact factor: 2.967

4.  Differential Expression of Potential Biomarkers of Oral Squamous Cell Carcinoma Development.

Authors:  Paola Fernandes Pansini; Isabella Bittencourt do Valle; Thabata Coeli Dias Damasceno; Priscila Marinho de Abreu; Anna Clara Gregório Có; Rossana Verónica Mendoza López; Jeferson Lenzi; Ricardo Mai Rocha; Evandro Duccini Souza; Maria Paula Curado; Hisham Mehanna; Paul Nankivell; José Roberto Vasconcelos de Podestá; Sandra Ventorin von Zeidler
Journal:  Head Neck Pathol       Date:  2021-04-11

5.  A new semisynthetic cardenolide analog 3β-[2-(1-amantadine)- 1-on-ethylamine]-digitoxigenin (AMANTADIG) affects G2/M cell cycle arrest and miRNA expression profiles and enhances proapoptotic survivin-2B expression in renal cell carcinoma cell lines.

Authors:  Elke Nolte; Sven Wach; Izabella Thais Silva; Sabine Lukat; Arif B Ekici; Jennifer Munkert; Frieder Müller-Uri; Wolfgang Kreis; Cláudia Maria Oliveira Simões; Julio Vera; Bernd Wullich; Helge Taubert; Xin Lai
Journal:  Oncotarget       Date:  2017-02-14

6.  On the discovery of a potential survivin inhibitor combining computational tools and cytotoxicity studies.

Authors:  Patricia A Quispe; Martin J Lavecchia; Ignacio E León
Journal:  Heliyon       Date:  2019-08-10

7.  BIRC5 Gene Disruption via CRISPR/Cas9n Platform Suppress Acute Myelocytic Leukemia Progression

Authors:  Manizheh Narimani; Mohammadreza Sharifi; Mohammad Saeed Hakhamaneshi; Daem Roshani; Mohammad Kazemi; Seyed Hossein Hejazi; Ali Jalili
Journal:  Iran Biomed J       Date:  2019-05-20

8.  Detection of urinary survivin using a magnetic particles-based chemiluminescence immunoassay for the preliminary diagnosis of bladder cancer and renal cell carcinoma combined with LAPTM4B.

Authors:  Yang Yang; Jianjun Xu; Qingyun Zhang
Journal:  Oncol Lett       Date:  2018-03-22       Impact factor: 2.967

9.  Pervasive Differential Splicing in Marek's Disease Virus can Discriminate CVI-988 Vaccine Strain from RB-1B Very Virulent Strain in Chicken Embryonic Fibroblasts.

Authors:  Yashar Sadigh; Abdessamad Tahiri-Alaoui; Stephen Spatz; Venugopal Nair; Paolo Ribeca
Journal:  Viruses       Date:  2020-03-18       Impact factor: 5.048

Review 10.  Emerging Importance of Survivin in Stem Cells and Cancer: the Development of New Cancer Therapeutics.

Authors:  Neerada Meenakshi Warrier; Prasoon Agarwal; Praveen Kumar
Journal:  Stem Cell Rev Rep       Date:  2020-10       Impact factor: 5.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.